ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2.51
-0.03
(-1.18%)
마감 18 1월 6:00AM
2.55
0.04
(1.59%)
시간외 거래: 9:43AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
2.55
매수가
-
매도가
-
거래량
2,382,822
2.47 일간 변동폭 2.605
1.43 52주 범위 4.1598
market_cap
전일 종가
2.54
개장가
2.57
최근 거래 시간
17
@
2.6
마지막 거래 시간
재정 규모
US$ 6,084,331
VWAP
2.5534
평균 볼륨(3m)
2,528,166
발행 주식
336,566,525
배당수익률
-
주가수익률
-11.10
주당순이익(EPS)
-0.23
매출
-
순이익
-75.8M

Panacea Acquisition Corp 정보

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker NUVB. The last closing price for Panacea Acquisition was US$2.54. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1.43 to US$ 4.1598.

Panacea Acquisition currently has 336,566,525 shares in issue. The market capitalisation of Panacea Acquisition is US$854.88 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -11.10.

NUVB 최신 뉴스

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief...

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Taletrectinib will be marketed in China by Innovent Biologics Approval is based on the pivotal Phase 2 TRUST-I study, demonstrating taletrectinib's durable responses and prolonged...

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.34-11.76470588242.892.992.4429811442.63521671CS
4-0.06-2.298850574712.613.4552.4429280532.79727153CS
120.2510.86956521742.33.4552.1825281662.73707239CS
26-0.8371-24.71435741493.38713.97219422912.77253868CS
520.9761.39240506331.584.15981.4316844762.82717362CS
156-3.3-56.41025641035.856.230.9511180912.72002284CS
260-7.45-74.51015.230.9510610114.20481321CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2.55
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336,566,525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 854.88M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1.43 to US$ 4.1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -11.1
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75.8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ARLAmerican Realty Investors Inc
US$ 15.93
(15.02%)
10.76k
RBOTVicarious Surgical Inc
US$ 16.382
(14.88%)
52.57k
AUNAAuna SA
US$ 8.45
(14.81%)
233.16k
MYTEMYT Netherlands Parent BV
US$ 9.45
(12.23%)
354.61k
BKSYBlackSky Technology Inc
US$ 11.71
(12.06%)
1.7M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M
DMDesktop Metal Inc
US$ 2.19
(-9.88%)
547.32k
JKSJinkosolar Holdings Co Ltd
US$ 21.23
(-9.81%)
1.55M
BODIBeachbody Company Inc
US$ 6.60
(-9.59%)
19.82k
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
FFord Motor Company
US$ 10.18
(1.70%)
60.8M
BBDBanco Bradesco SA
US$ 1.96
(-1.01%)
59.92M
VALEVale SA
US$ 8.94
(1.94%)
59.4M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M

NUVB Discussion

게시물 보기
Monksdream Monksdream 5 월 전
NUVB under $4
👍️0
Monksdream Monksdream 6 월 전
NUVB under $3
👍️0
littlefish littlefish 7 월 전
Looks decent, I’ve been building a position around $3 lately.
👍️0
Monksdream Monksdream 8 월 전
NUVB under $5
👍️0
glenn1919 glenn1919 10 월 전
NUVB.............................................https://stockcharts.com/h-sc/ui?s=NUVBB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 10 월 전
looking strong a/h trading
👍️0
glenn1919 glenn1919 10 월 전
NUVB..............................https://stockcharts.com/h-sc/ui?s=NUVB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 10 월 전
busting 4 bucks now, weeee!!
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
NUVB...COMING OUT OF A MONTHLY TIGHT BAND...THATS WHY THE MONSTER MOVE!!!
👍️0
gail gail 10 월 전
i must say, i have seen…….



you on many stocks you hated, but im relieved to see you like this one. that says something.
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
SUPER THIN....THE POWER OF A WEEKLY BREAK OUT...BULLISH AS FUC
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
NUVB...HERE COMES 4 DOLLA
👍️0
gail gail 10 월 전
it does move well, daily!
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
nuvb...here we go....bio beast
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
NUVB...MONSTA
👍️0
tw0122 tw0122 10 월 전
New price target $10 by Jeffries from $1.40
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
nuvb...big gapper
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
NUVB next bio beast
👍️0
Monksdream Monksdream 10 월 전
NUVB new 52 hi
👍️0
Monksdream Monksdream 10 월 전
NUVB new 52 week high
👍️0
Monksdream Monksdream 11 월 전
NUVB new 52 week high
👍️0

최근 히스토리

Delayed Upgrade Clock